Patricia Fetsch

5.3k total citations
73 papers, 3.9k citations indexed

About

Patricia Fetsch is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Patricia Fetsch has authored 73 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 25 papers in Immunology and 23 papers in Molecular Biology. Recurrent topics in Patricia Fetsch's work include Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (13 papers) and Occupational and environmental lung diseases (9 papers). Patricia Fetsch is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (13 papers) and Occupational and environmental lung diseases (9 papers). Patricia Fetsch collaborates with scholars based in United States, Italy and Malaysia. Patricia Fetsch's co-authors include Andrea Abati, Susan E. Bates, Francesco M. Marincola, Yasmine M. Hijazi, Thomas Litman, Janice N. Cormier, Armando Filie, Aylin Simsir, Robert W. Robey and Michael Dean and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Patricia Fetsch

73 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia Fetsch United States	35	2.1k	1.3k	967	752	403	73	3.9k
Andrea Abati United States	38	1.9k 0.9×	1.1k 0.8×	818 0.8×	945 1.3×	807 2.0×	97	4.6k
Lothar Bergmann Germany	39	1.4k 0.6×	2.1k 1.5×	1.0k 1.1×	813 1.1×	240 0.6×	182	4.8k
Martin Sattler United States	55	2.4k 1.1×	4.3k 3.2×	1.2k 1.3×	694 0.9×	302 0.7×	151	8.6k
Alessandro Pileri Italy	44	3.2k 1.5×	2.1k 1.5×	1.9k 2.0×	307 0.4×	248 0.6×	335	8.2k
Jung-Mao Hsu Taiwan	35	3.0k 1.4×	3.5k 2.6×	1.6k 1.7×	730 1.0×	327 0.8×	56	6.1k
Marco Novelli United Kingdom	30	799 0.4×	739 0.5×	501 0.5×	907 1.2×	933 2.3×	84	3.4k
Kiyohiko Hatake Japan	41	2.3k 1.1×	1.3k 1.0×	1.2k 1.3×	736 1.0×	361 0.9×	237	5.1k
Albert Deisseroth United States	40	2.4k 1.1×	2.6k 2.0×	1.0k 1.0×	289 0.4×	242 0.6×	139	5.7k
Nam H. Dang United States	49	4.2k 2.0×	2.2k 1.6×	1.7k 1.7×	662 0.9×	309 0.8×	194	7.6k
Beatríz Bellosillo Spain	45	2.3k 1.1×	2.9k 2.2×	1.3k 1.4×	980 1.3×	391 1.0×	231	7.6k

Countries citing papers authored by Patricia Fetsch

Since Specialization

Citations

This map shows the geographic impact of Patricia Fetsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Fetsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Fetsch more than expected).

Fields of papers citing papers by Patricia Fetsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Fetsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Fetsch. The network helps show where Patricia Fetsch may publish in the future.

Co-authorship network of co-authors of Patricia Fetsch

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Fetsch. A scholar is included among the top collaborators of Patricia Fetsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Fetsch. Patricia Fetsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pemov, Alexander, Nancy F. Hansen, Sivasish Sindiri, et al.. (2019). Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1–associated atypical neurofibromas. Neuro-Oncology. 21(8). 981–992. 69 indexed citations

Pratt, Drew, Stefania Pittaluga, Maryknoll Palisoc, et al.. (2017). Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma. Journal of Neuropathology & Experimental Neurology. 76(8). 697–708. 14 indexed citations

Rao, Mahadev, Vivek Shukla, Young Ki Hong, et al.. (2015). Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells. Clinical Cancer Research. 22(5). 1197–1210. 25 indexed citations

Bartlett, Edmund K., Patricia Fetsch, Armando Filie, et al.. (2014). Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration. Clinical Cancer Research. 20(10). 2607–2616. 21 indexed citations

Murtas, Daniela, Dragan Maric, Valeria De Giorgi, et al.. (2013). IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes. British Journal of Cancer. 109(1). 76–82. 51 indexed citations

Zhang, Mary, Aarti Mathur, Yuwei Zhang, et al.. (2012). Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells. Cancer Research. 72(16). 4178–4192. 82 indexed citations

Kemp, Clinton D., Mahadev Rao, Sichuan Xi, et al.. (2011). Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy. Clinical Cancer Research. 18(1). 77–90. 77 indexed citations

Panelli, Monica C., Mitchell E. Stashower, Herbert B. Slade, et al.. (2007). Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome biology. 8(1). R8–R8. 79 indexed citations

Fetsch, Patricia & Andrea Abati. (2007). The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature. Diagnostic Cytopathology. 35(6). 319–328. 11 indexed citations

10.

Fetsch, Patricia & Andrea Abati. (2003). Overview of the Clinical Immunohistochemistry Laboratory: Regulations and Troubleshooting Guidelines. Humana Press eBooks. 115. 405–414. 11 indexed citations

11.

Fetsch, Patricia, Nicole L. Simone, Peter Bryant-Greenwood, et al.. (2002). Proteomic Evaluation of Archival Cytologic Material Using SELDI Affinity Mass Spectrometry. American Journal of Clinical Pathology. 118(6). 870–876. 49 indexed citations

12.

Litman, Thomas, Alastair Hansen, Zhirong Zhan, et al.. (2002). Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1565(1). 6–16. 103 indexed citations

13.

Ohnmacht, Galen A., Ena Wang, Simone Mocellin, et al.. (2001). Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination. The Journal of Immunology. 167(3). 1809–1820. 69 indexed citations

14.

Mocellin, Simone, Patricia Fetsch, Andrea Abati, et al.. (2001). Laser Scanning Cytometry Evaluation of MART-1, gp100, and HLA-A2 Expression in Melanoma Metastases. Journal of Immunotherapy. 24(6). 447–458. 10 indexed citations

15.

Simsir, Aylin, et al.. (1999). E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless. Diagnostic Cytopathology. 20(3). 125–130. 73 indexed citations

16.

Simsir, Aylin, Patricia Fetsch, Maryalice Stetler‐Stevenson, & Andrea Abati. (1999). Immunophenotypic analysis of non-hodgkin's lymphomas in cytologic specimens: A correlative study of immunocytochemical and flow cytometric techniques. Diagnostic Cytopathology. 20(5). 278–284. 34 indexed citations

17.

Riker, Adam I., Monica C. Panelli, Udai S. Kammula, et al.. (1999). Development and Characterization of Melanoma Cell Lines Established by Fine-Needle Aspiration Biopsy: Advances in the Monitoring of Patients with Metastatic Melanoma. Cancer Detection and Prevention. 23(5). 387–396. 26 indexed citations

18.

Nagaraju, Kanneboyina, Nina Raben, María L. Villalba, et al.. (1999). Costimulatory Markers in Muscle of Patients with Idiopathic Inflammatory Myopathies and in Cultured Muscle Cells. Clinical Immunology. 92(2). 161–169. 83 indexed citations

19.

Cormier, Janice N., Yasmine M. Hijazi, Andrea Abati, et al.. (1998). Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. International Journal of Cancer. 75(4). 517–524. 139 indexed citations

20.

Tolcher, Anthony W., Kenneth H. Cowan, D. Solomon, et al.. (1996). Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.. Journal of Clinical Oncology. 14(4). 1173–1184. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact